Physician profile
Philip E Havens
NPI 1184602278
$1,126.82
in general payments reported to CMS, 2019-2025
13 companies · $73.81 in 2025
The $73.81 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2021: $14.36 · 2022: $236 · 2023: $136 · 2024: $177 · 2025: $73.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $417.65 | 2019-2024 | Persona |
| Depuy Synthes Sales INC. | $204.56 | 2019-2025 | Na, Crosstie |
| Alexion Pharmaceuticals, INC. | $125.00 | 2024 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $98.43 | 2022 | |
| Pacira Therapeutics, INC. | $50.11 | 2019 | |
| Ferring Pharmaceuticals INC. | $42.60 | 2019 | |
| Bioventus LLC | $40.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.00 | 2019 | |
| Novo Nordisk INC | $35.00 | 2025 | Wegovy |
| Stryker Corporation | $27.30 | 2019 | |
| Convatec INC. | $19.27 | 2019 | |
| Arteriocyte Medical Systems, INC. | $13.63 | 2019 | |
| Kci USA, INC. | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Havens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.